Drug Shortages Prior to and During the COVID-19 Pandemic
This cross-sectional study examines the proportion of supply chain issue reports associated with drug shortages overall and during the COVID-19 pandemic.
This cross-sectional study examines the proportion of supply chain issue reports associated with drug shortages overall and during the COVID-19 pandemic.
The Agency for Healthcare Research and Quality (AHRQ) Making Healthcare Safer (MHS) reports consolidate information for healthcare providers, health system administrators, researchers, and government agencies…
The purpose of this systematic review was to document and summarize reported barriers and facilitators to the receipt of selected clinical preventive services among people…
March 2024 R. Henry Olaisen, Ph.D., M.P.H., P.M.P., and Marc Roemer, M.S. Prior to the COVID-19 pandemic, 95 percent of all emergency department (ED) visits…
AHRQ advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.
This systematic review and consensus statement reviews literature on the definition of neurological device abandonment and develops a consensus definition.
Use of digital healthcare technologies – for clinicians and patients – is growing. To ensure these solutions benefit all patient groups, creators and users must be…
Dementia is a devastating neurologic condition now accounting for more than 100 000 deaths annually in the US. Symptoms typically begin as mild difficulties with memory…
Effective screening and referral practices for perinatal mental health disorders, perinatal substance use disorders (SUDs), and intimate partner violence are greatly needed to reduce maternal…
This webcast discussed Indiana Hospital Association’s experiences using the Surveys on Patient Safety Culture® (SOPS®) Hospital Survey and Workplace Safety Item Set. They shared their…
Show Talk Evidence, Ep Will semaglutide buck the trend of other weight loss drugs? – 19 Apr 2024